Lessons for investors from Theranos
Due diligence is on trial in the Theranos case. Today's funding environment has compressed the deal windows for hot startups. Could it happen again?
brian grossman
To give you the best possible experience, this site uses cookies. If you continue browsing. you accept our use of cookies. You can review our privacy policy to find out more about the cookies we use.